glp 1 agonist microdosing GLP-1 EllieMD | GLP-1/GIP + B12
Description
doi: 10.1111/dom.12121
Patients who had been tracking their tirzepatide dosage in units suddenly needed to track their out-of-pocket expenses as well
Key takeaways Health insurance companies may stop covering GLP-1 medications for weight loss due to their rising costs and questions about their necessity
sales surpassing $13 billion cementing its role as a cultural and clinical phenomenon
Styne DM, Arslanian SA, Connor EL, Farooqi IS, Murad MH, Silverstein JH, et al
